Skip to main content

Want a detailed portfolio tracker?

Maravai LifeSciences (MRVI) P/E (2021 - 2026)

Maravai LifeSciences (MRVI) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Maravai LifeSciences (MRVI) P/E is -5.28. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Maravai LifeSciences (MRVI)

YearP/EChange
2026-5.28+118.46%
2025-2.42-60.20%
2024-6.07-122.14%
202327.41+253.15%
20227.76-79.02%
202136.99N/A

Comparison Maravai LifeSciences (MRVI) P/E with competitors

Maravai LifeSciences (MRVI) P/E is -5.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.42%
FGENFibroGen Inc0.24-104.55%
CHRSCoherus Biosciences Inc0.85-116.08%
FBIOFortress Biotech Inc0.95-117.99%
ORMPOramed Pharmaceuticals Inc1.50-128.49%
AGENAgenus Inc3.01-157.04%
INVAInnoviva Inc3.15-159.77%
VXRTVaxart Inc3.55-167.27%
CRMDCorMedix Inc3.63-168.77%
CVACCureVac N.V.4.45-184.25%
GLPGGalapagos NV4.86-192.08%
SRPTSarepta Therapeutics Inc4.88-192.52%
ABEOAbeona Therapeutics Inc5.39-202.10%
ABUSArbutus Biopharma Corp5.60-206.05%
ZVRAZevra Therapeutics Inc5.89-211.57%
SPROSpero Therapeutics Inc6.23-218.04%
CGENCompugen Ltd6.31-219.66%
RIGLRigel Pharmaceuticals6.87-230.24%
SLXNSilexion Therapeutics Corp7.30-238.27%
OMEROmeros Corporation9.26-275.47%
AUPHAurinia Pharmaceuticals Inc9.58-281.65%
PLXProtalix BioTherapeutics Inc10.89-306.41%
ACADAcadia Pharmaceuticals Inc11.73-322.28%
TBPHTheravance Biopharma Inc12.26-332.39%
ADMAAdma Biologics Inc12.42-335.35%
HRMYHarmony Biosciences Holdings Inc13.82-361.92%
SABSSAB Biotherapeutics Inc14.14-367.91%
NAGENiagen Bioscience Inc14.82-380.83%
INCYIncyte Corp15.82-399.87%
REGNRegeneron Pharmaceuticals Inc15.86-400.51%
PBYIPuma Biotechnology Inc17.32-428.17%
CPRXCatalyst Pharmaceuticals Inc17.44-430.51%
EXELExelixis Inc17.54-432.38%
TGTXTG Therapeutics Inc18.97-459.44%
MDXGMimedx Group Inc20.55-489.51%
XOMAXOMA Royalty Corp22.87-533.53%
ARGXArgen X SE24.30-560.51%
CTMXCytomX Therapeutics Inc24.82-570.42%
XOMAOXOMA Royalty Corp25.34-580.35%
HALOHalozyme Therapeutics Inc25.62-585.63%
XOMAPXOMA Royalty Corp25.67-586.51%
VRTXVertex Pharmaceuticals Inc27.99-630.57%
RPRXRoyalty Pharma plc - Class A28.69-643.70%
SLNOSoleno Therapeutics Inc29.02-649.91%
ASNDAscendis Pharma A/S30.09-670.19%
LGNDLigand Pharmaceuticals Inc - Class B37.91-818.52%
APLSApellis Pharmaceuticals Inc39.02-839.55%
BMRNBiomarin Pharmaceutical Inc42.21-900.02%
KRYSKrystal Biotech Inc45.34-959.37%
ONCBeiGene Ltd69.54-1417.96%
PHARPharming Group N.V.75.03-1521.92%
TECHBio-Techne Corp101.96-2032.36%
VCELVericel Corp109.92-2183.28%
ALNYAlnylam Pharmaceuticals Inc117.96-2335.73%
GMABGenmab140.29-2758.85%
TLXTelix Pharmaceuticals Ltd162.15-3173.19%
CORTCorcept Therapeutics Inc212.86-4134.17%